DEMETRIOS KAIAFAS: Open Payments
NPI 1386676773 · BELLEAIR, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,445 in 74 payments from 9 companies in 2025. Trend: 2023 $791 · 2024 $938 · 2025 $1,445
Food & beverage: $1,445
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 33 | $707 |
| Globus Medical, Inc. | 16 | $170 |
| TerSera Therapeutics LLC | 6 | $161 |
| Collegium Pharmaceutical, Inc. | 9 | $139 |
| Nalu Medical, Inc. | 3 | $97 |
| Medtronic, Inc. | 3 | $59 |
| MML US, Inc. | 1 | $55 |
| ABBVIE INC. | 2 | $42 |
| Fidia Pharma USA Inc. | 1 | $15 |
Products named: WaveWriter Alpha Prime 16, Senza, Prialt, XTAMPZA, Nalu Neurostimulation System, INCEPTIV, ReActiv8, General - Pain Management.
Industry payments across FL — which companies pay providers there.
